ProCE Banner Activity


Getting Ahead of the Pain: Preventive Options for Migraine

Podcast Episodes

Many patients with migraine may be candidates for preventive pharmacotherapies—either in addition to or in place of acute options. With an expanding range of preventive agents, choosing the optimal one for individual patients can become confusing. In this podcast episode, 2 experts in migraine provide clinical pearls focused on preventing migraine. Listen as they discuss patient factors that indicate preventive treatment is warranted, the range of available preventive treatments and their use in practice, and strategies for engaging patients in their care.

To access episode 1, click here.

Registered Nurses: 0.50 Nursing contact hours, includes 0.50 hour of pharmacology credit Physician Assistants: maximum of 0.50 hours of AAPA Category 1 CME credits

Released: March 31, 2022

Expiration: March 30, 2023

No longer available for credit.
Begin Activity



Maureen Moriarty

Maureen Moriarty, DNP, ANP-BC

Associate Professor
Malek School of Nursing Professions
Marymount University
Arlington, Virginia
Moriarty Associates: A Comprehensive Headache Center
Westminster, Maryland

Karen A. Williams

Karen A. Williams, DNP, FNP-BC, AQH

KDW Health Management
Pensacola, Florida


This activity is supported by educational funding provided by Amgen and AbbVie Inc.

Provided by

ProCE Banner

Target Audience

NPs and PAs in primary care

Learning Objectives

Upon completion of this activity, participants should be able to:
  • Assess efficacy and safety evidence for novel therapies to prevent migraine

  • Formulate treatment strategies for prevention of migraine in patients


All faculty and planners participating in continuing education activities sponsored by Practicing Clinicians Exchange (PCE) are required to disclose all financial relationships with ineligible companies. All relevant conflicts of interest are thoroughly vetted and mitigated according to PCE policy. In addition, all faculty are required to openly disclose any off-label, experimental, or investigational use of drugs or devices discussed in this activity. The faculty and Planning Committee have been advised that this activity must be free from commercial bias and based upon all available scientifically rigorous data from research that conforms to accepted standards of experimental design, data collection, and analysis.

Dr Moriarty: consultant/advisor/speaker: AbbVie/Allergan, Amgen, Biohaven, Lilly; researcher: Teva.

Dr Williams: consultant/advisor/speaker: Biohaven.

Ms Zimmerman: research support/fees for non-CME/CE services: BioDelivery Sciences International.

None of the members of the PCE staff have any relevant relationships to disclose.

Instructions for Credit

Participants wishing to earn CE/CME credit must:

  1. Listen to the content in its entirety
  2. Relate the content material to the learning objectives
  3. Complete the post-test and evaluation form

Successful completion of the post-test is required to earn CE/CME credit. Successful completion is defined as a cumulative score of 100%.

The estimated time to complete this activity is 0.50 hours.

Release date: March 31, 2022
Expiration date: March 30, 2023




The opinions or views expressed in this CE/CME activity do not necessarily reflect the opinions or recommendations of Practicing Clinicians Exchange or any educational supporter.



Joint Accreditation Statement

Joint AccreditationIn support of improving patient care, Practicing Clinicians Exchange is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

ANCC Credit Designation

Nursing contact hours: 0.50, which includes 0.50 hours of pharmacology credit

AAPA Credit Designation

Joint AccreditationPracticing Clinicians Exchange has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 0.50 AAPA Category 1 CME credits. Approval is valid until March 30, 2023. PAs should only claim credit commensurate with the extent of their participation.

PA course advisor: Mandy Zimmerman, PA-C, West Forsyth Pain Management, Winston-Salem, North Carolina

IPCE Credit Designation
IPCEThis activity was planned by and for the healthcare team, and learners will receive 0.50 Interprofessional Continuing Education (IPCE) credits for learning and change.

Additional Information

Program Medium

This program has been made available online.